WASHINGTON, D.C. — A growing number of wellness‑focused consumers say they began using kratom after hearing it promoted on podcasts, receiving free samples at gyms, or seeing fitness influencers tout its “natural” energy boost, only to develop dependence within months.

Clinical studies on kratom’s active alkaloids, mitragynine and 7‑hydroxymitragynine, remain limited. A 2023 review in *JAMA Network Open* found modest analgesic effects but highlighted a 15‑percent incidence of withdrawal symptoms among regular users. The U.S. Food and Drug Administration has not approved kratom for any medical use and has issued 23 warning letters to retailers for marketing the herb as a dietary supplement.

KEY POINTClinical studies on kratom’s active alkaloids, mitragynine and 7‑hydroxymitragynine, remain limited.

“Patients often come to us believing kratom is a harmless herb,” said Dr. Emily Chen, an addiction specialist at the National Institute on Drug Abuse. “When they experience cravings, insomnia and gastrointestinal distress, it becomes a clinical challenge because there are no FDA‑approved treatment protocols.” In a 2022 survey of 1,200 gym members, 12 percent reported having tried kratom at least once, and 4 percent said they continued regular use.

Former user Mark Davis, 34, recounted his experience: “I started with a single capsule a day after a podcast suggested it could help my post‑workout recovery. Within three weeks I was taking three to four doses and couldn’t stop without feeling shaky and irritable.” Health providers are increasingly screening for kratom during routine visits, noting that abrupt cessation can lead to symptoms similar to opioid withdrawal.

Key Takeaways

• Kratom is not FDA‑approved; the agency has issued multiple warnings against unsubstantiated health claims.
• Clinical evidence shows potential analgesic benefits but also a measurable risk of dependence and withdrawal.
• Patients reporting kratom use should be assessed for addiction and guided toward evidence‑based treatment options.

As awareness of kratom’s risks spreads, public‑health officials stress the importance of evidence‑based information rather than anecdotal promotion, urging consumers to consult health professionals before experimenting with unregulated botanicals.